COVID-19 and lymphangioleiomyomatosis: Experience at a reference center and the potential impact of the use of mTOR inhibitors.

Authors :: Baldi BG
Amaral AF
de Figueiredo Braga Colares P
Kairalla RA
de Oliveira MR
Carvalho CRR
Source :: American journal of medical genetics. Part A [Am J Med Genet A] 2020 Dec; Vol. 182 (12), pp. 3068-3070. Date of Electronic Publication: 2020 Sep 18.
Publication Year :: 2020

Subjects :: Humans
Pandemics
TOR Serine-Threonine Kinases
COVID-19
Lymphangioleiomyomatosis

Full Text Access

Tools